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The capsule polysaccharide locus (cps) is the site of the capsule biosynthesis gene cluster in
encapsulated Streptococcus pneumoniae. A set of pneumococcal samples and non-
pneumococcal streptococci from Denmark, the Gambia, the Netherlands, Thailand, the UK and
the USA were sequenced at the cps locus to elucidate serologically mistyped or non-typable
isolates. We identified a novel serotype 33B/33C mosaic capsule cluster and previously unseen
serotype 22F capsule genes, disrupted and deleted cps clusters, the presence of aliB and nspA
genes that are unrelated to capsule production, and similar genes in the non-pneumococcal
samples. These data provide greater understanding of diversity at a locus which is crucial to the
antigenic diversity of the pathogen and current vaccine strategies.
INTRODUCTION
Streptococcus pneumoniae is a widespread nasopharyngeal
commensal and pathogen of humans, causing a range of
conditions, including otitis media, sinusitis, pneumonia,
septicaemia and meningitis, and is usually associated with
disease in infants, the elderly and immunocompromised
individuals. In the year 2000, an estimated 14.5 million
cases of severe pneumococcal disease occurred worldwide in
children aged under 5 years, causing approximately 11% of
all deaths in that age group (O’Brien et al.,2 0 0 9 ) .T h e
polysaccharide capsule, which has a variable structure divided
into more than 90 serotypes, is the major known virulence
factor, being important for survival in the blood and strongly
associated with antiphagocytic activity (Kim et al., 1999). The
capsule induces protective antibodies, and is the basis for
the 23-valent polysaccharide and 7-valent conjugate vaccines
(pneumococcal conjugate vaccines; PCVs) that are licensed
in over 70 countries, as well as the recently licensed 10- and
13-valent conjugate vaccines.
Some serotypes have been found to be more likely to occur in
cases of invasive disease, relative to exposure through carriage
(Brueggemann et al., 2004; Hanage et al., 2005). Before the
use of the 7-valent conjugate vaccine in children, serotype 14
was the most common cause of invasive pneumococcal
disease (IPD) globally (Johnson et al.,2 0 1 0 ) .T h e r ei ss o m e
evidence that certain capsule structures better enable survival
in carriage and infection (Melin et al., 2010; Weinberger et al.,
2009), although disease outcome can be independent of
serotype in capsular switch experiments (Mizrachi Nebenzahl
et al., 2004). Since the introduction of the 7-valent vaccine
among infants, cases of IPD attributable to vaccine serotypes
have reduced, but other types persist in causing disease such
as serotype 1 across Europe, Asia, Latin America and Africa
(Kirkham et al., 2006), or multidrug-resistant 19A in Spain
(Mun ˜oz-Almagro et al.,2 0 0 9 ) ,I s r a e l( D a g a net al., 2009),
across Asia (Shin et al., 2011) and in the USA (Beall et al.,
2011; Moore et al., 2008).
Abbreviations: array CGH, array comparative genomic hybridization; NT,
non-typable; RUP element, repeat unit of pneumococcus element.
Two supplementary tables are available with the online version of this
paper.
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mediated by the Wzx/Wzy-dependent pathway encoded by
genes at the cps (capsular polysaccharide synthesis) locus.
Thecpslocus is located betweentheglucan1,6-a-glucosidase
gene dexB and the oligopeptide ABC transporter gene aliA,
which are not involved in capsule synthesis. The Wzx/Wzy-
dependent pathway involves several transferases that create a
polysaccharide subunit which is polymerized and translo-
cated across the membrane (Bentley et al., 2006). Each
serotype possesses a unique combination of cps genes or
alleles. The alternative synthase pathway is found in two
serotypes, 3 and 37. A single synthase gene is responsible for
the production of these capsule types (Llull et al., 1999;
Paton & Morona, 2007).
Changes at the cps locus can affect capsule expression by
several mechanisms. Slipped-strand mispairing causes a gene
truncation, which is the root of the difference between
serotypes 15B and 15C (van Selm et al., 2003). The pheno-
menon of serotype switching refers to cases of recombination
leading to the replacement of either a part or the entirety of
the cps locus with the homologous region from a strain of
another serotype. Serotype switching has been observed many
times in nature (Croucher et al., 2011) and demonstrated
in the laboratory (Weinberger et al., 2009). These variations
have implications for serotype-specific vaccines, and several
studies have shown switched clones arising in vaccinated
populations (Ansaldi et al., 2011; Brueggemann et al., 2007;
Temime et al., 2008). As well as variation in capsule pro-
duction during infection (Hammerschmidt et al., 2005),
spontaneous loss of capsule has been observed in vitro,w h e r e
a single culture may sequentially lose and regain capsule
production (Waite et al., 2003), and may therefore be
inconsistently reactive to typing sera.
Pneumococci designated non-typable (NT) may possess a
capsule for which there are no typing antisera, they may
produce the capsule erratically, or they may be non-
encapsulated. Non-typable pneumococci are widely found
in carriage studies and non-invasive disease episodes
(Marsh et al., 2010) but rarely in IPD. NT S. pneumoniae
are poorly characterized compared with encapsulated
strains, despite their common occurrence and potential for
acting as a reservoir of genetic variety in the nasopharynx.
The objective of this study was to investigate the cps gene
content of pneumococci which are not serologically typable
or which were shown by microarray analysis to possess non-
standard capsular gene clusters. Isolates referred from a
molecular typing array included those with non-standard
combinations of identifiable cps genes, suspected deletions
or novel genes, and other streptococci which appeared to
possess pneumococcal-like genes.
METHODS
Isolates. Fifty-eight isolates, described in Tables 1 and S1, were
obtained from Denmark (two S. pneumoniae, three non-pneumo-
coccus), the Gambia (five S. pneumoniae, three non-pneumococcus),
the Netherlands (nine S. pneumoniae, one non-pneumococcus),
Thailand (18 S. pneumoniae, one non-pneumococcus), the UK (three
S. pneumoniae, three non-pneumococcus) and the USA (10 S.
pneumoniae). All isolates had been examined by capsular reaction test
at the time of isolation, and DNA extracts were then analysed on the
BmG@S SP-CPS v1.3.0 molecular serotyping array (Brugger et al.,
2010; Turner et al., 2011) using standard Agilent 8615K format array
comparative genomic hybridization (array CGH) enzymic labelling
and hybridization protocols. Fourteen pneumococcal isolates had no
identifiable cps genes and no positive serological result, 30 had an
incomplete list of genes and no serotype, three possessed genes that
differed from their serological result, and 11 non-pneumococcal
streptococci had pneumococcal cps genes.
Species identification. Strains used in this study were identified at
the time of isolation as S. pneumoniae or other streptococcal species
by standard microbiological methods such as optochin sensitivity and
bile solubility. The assigned species were confirmed by array CGH
analysis of the S. pneumoniae genome backbone component of the
molecular serotyping array, then further verified by sequencing of 16S
rRNA genes and manual analysis of the V2, V4 and V5 hypervariable
regions compared with a reference set of streptococcal sequences from
the Ribosomal Database Project (RDP) (Cole et al., 2007). The non-
pneumococcal isolates in the study were included to follow up the
detection of cps genes during blind-test analysis on the serotyping
array.
PCR of the cps region. All PCRs were performed using the TaKaRa
LA PCR kit in 50 ml final volumes sealed with mineral oil, according
to the manufacturer’s instructions. Amplification of the complete cps
region was achieved using primers within the flanking genes dexB
and aliA (Table 2). Where the products were of unknown length, a
touchdown PCR program was used, varying the annealing temper-
ature from 68 to 60 uC (decreasing over eight cycles), and then the
extension time from 22 to 31 min (increasing over 27 cycles). For
cases where the size of the product was known to be 10 kb or under, a
simple PCR program using a 60 uC annealing temperature and
10 min, 72 uC extension was used. Products were checked by gel
electrophoresis before sequencing.
Screening primers for genes of interest were generated from the
established sequence, and used to assess the content of the remaining
sampleset wherefullcps PCR was not successful (see Table 2 for primers,
and Table S2 for supplementary primers and screening protocols).
Sequencing. For large PCR products, short insert libraries were
created (McMurray et al., 1998) and sequenced by capillary. Small PCR
products (under 1.5 kb)were end-sequenced by capillary (Sanger et al.,
1977).
Analysis. The sequence data were aligned and manipulated in Gap4
(Bonfield et al., 1995), genes were predicted using Glimmer3 (Delcher
et al., 1999) and visualized and curated in Artemis (Rutherford et al.,
2000), and conserved domains were identified using MotifScan (Hulo
et al., 2008). Insertion sequences were identified using the IS Finder
database (Siguier et al., 2006). Alignments and trees were constructed
using Muscle (Edgar, 2004) and Seaview (Gouy et al., 2010),
respectively. Trees were created using the Bio-NJ Jukes–Cantor
distance method.
RESULTS
Sequencing results are shown in Table S1 and divided into
five groups: functional cps clusters producing a polysac-
charide capsule but with genes different to the reference
strains (Bentley et al., 2006) (Fig. 1a), complete or partial
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Sample name [GenBank accession no.] Species Country of origin Serotype* Non-typable group
557B [HE651321] S. pneumoniae Denmark 33C Serotype and microarray
results differ
L2008-01622 [HE651300] S. pneumoniae USA 22F
1772-40b [HE651318] S. pneumoniae Denmark 22F
2489-06 [HE651319] S. pneumoniae USA Non-encapsulated Group NT1: cps deletion
GM90852 [HE651312] S. pneumoniae The Gambia Non-encapsulated
GM108225 [HE651315] S. pneumoniae The Gambia Non-encapsulated
L2008-01621 [HE651299] S. pneumoniae USA Non-encapsulated
L2008-01629 [HE651301] S. pneumoniae USA Non-encapsulated
L2008-01630 [HE651302] S. pneumoniae USA Non-encapsulated
L2008-01636 [HE651303] S. pneumoniae USA Non-encapsulated
GM96650 [HE651314] S. pneumoniae The Gambia Non-encapsulated
07B00725 [HE651278] S. pneumoniae Thailand Non-encapsulated Group NT2: putative
surface protein NspA
07B00751 [HE651279] S. pneumoniae Thailand Non-encapsulated
07B00782 [HE651280] S. pneumoniae Thailand Non-encapsulated
07B00890 [HE651283] S. pneumoniae Thailand Non-encapsulated
07B00933 [HE651286] S. pneumoniae Thailand Non-encapsulated
08B01575 [HE651297] S. pneumoniae Thailand Non-encapsulated
08B00936 [HE651287] S. pneumoniae Thailand Non-encapsulated
08B01425 [HE651289] S. pneumoniae Thailand Non-encapsulated
RUNMC819 [HE651281] S. pneumoniae The Netherlands Non-encapsulated
07B00830 [HE651282] S. pneumoniae Thailand Non-encapsulated
08B00930 [HE651285] S. pneumoniae Thailand Non-encapsulated
RUNMC2437 [HE651308] S. pneumoniae The Netherlands Non-encapsulated
0900-07 [HE651316] S. pneumoniae USA Non-encapsulated Group NT3: aliB genes
3039 [HE651275] S. pneumoniae UK Non-encapsulated
07-047 [HE651276] S. pneumoniae UK Non-encapsulated
RUNMC1664 [HE651304] S. pneumoniae The Netherlands Non-encapsulated
RUNMC1988 [HE651307] S. pneumoniae The Netherlands Non-encapsulated
RUNMC3306 [HE651310] S. pneumoniae The Netherlands Non-encapsulated
2566-06 [HE651320] S. pneumoniae USA Non-encapsulated
RUNMC1437 [HE651290] S. pneumoniae The Netherlands Non-encapsulated
RUNMC2945 [HE651309] S. pneumoniae The Netherlands Non-encapsulated
625 [HE651277] S. pneumoniae UK Non-encapsulated
RUNMC1897 [HE651306] S. pneumoniae The Netherlands Non-encapsulated
L2008-01618 [HE651298] S. pneumoniae USA Non-encapsulated
1878-08 [HE651317] S. pneumoniae USA Non-encapsulated
08B00915 [HE651284] S. pneumoniae Thailand Non-encapsulated
07B00945 [HE651288] S. pneumoniae Thailand Non-encapsulated
08B01481 [HE651292] S. pneumoniae Thailand Non-encapsulated
08B01482 [HE651293] S. pneumoniae Thailand Non-encapsulated
08B01463 [HE651291] S. pneumoniae Thailand Non-encapsulated
08B01483 [HE651294] S. pneumoniae Thailand Non-encapsulated
08B01531 [HE651296] S. pneumoniae Thailand Non-encapsulated
RUNMC1739 [HE651305] S. pneumoniae The Netherlands Non-encapsulated
08B01484 [HE651295] S. pneumoniae Thailand Non-encapsulated
GM15912 [HE651311] S. pneumoniae The Gambia Non-encapsulated
GM90967 [HE651313] S. pneumoniae The Gambia Non-encapsulated
IOPR 1791 [HE651264] S. pseudopneumoniae UK Non-encapsulated Non-pneumococcal
streptococci
IOPR 5427 [HE651265] S. pseudopneumoniae UK Non-encapsulated
VS10 [HE651271] S. mitis UK Non-encapsulated
07B00902 [HE651266] S. pseudopneumoniae Thailand Non-encapsulated
RUNMC2031 [HE651272] S. mitis The Netherlands Non-encapsulated
GM56393 [HE651267] S. pseudopneumoniae The Gambia Non-encapsulated
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functional (group NT1) (Fig. 1b, c), cps containing a novel
putative surface protein gene (group NT2) (Fig. 1e), cps
containing a conserved aliB gene cluster (group NT3) (Fig.
1f), and non-pneumococcal streptococci with a similar aliB
gene cluster. These five groups are summarized below.
Three samples were referred from array analysis as they
produced a capsule which conflicted serologically with
the array prediction. Strain 557B (GenBank accession no.
HE651321) is serotype 33C by Quellung reaction, with a
mixture of 33B- and 33C-like genes as designated by array.
Sequencing of the entire region confirmed that this isolate
has a mosaic cps cluster of 33B and 33C genes with a
divergent wzx and wzy. Samples 1772-40b and L2008-01622
(accession nos HE651300 and HE651318) are serotype 22F
butwithtwogenesabsentaccordingtoarrayresult.Targeted
sequencing of the expected location of these genes showed
two novel genes, predicted to serve the same function as
those in the reference sequence.
Three non-encapsulated samples (accession nos HE651312,
HE651315, HE651319) had no cps genes when tested with
the array and upon sequencing were found to have had the
entire cluster deleted. A further five samples (accession nos
HE651299, HE651301, HE651302, HE651303, HE651314)
were shown to have undergone partialdeletions of the capsule
biosynthesis cluster, rendering them non-functional.
In addition to the three isolates with complete cps deletions,
12 samples that had no genes represented on the array were
sequenced and found to possess a putative novel surface
proteingene(nspA)at thelocus along with a variety of intact
and disrupted IS elements (accession nos HE651278–83,
HE651285–7, HE651289, HE651297, HE651308). The nspA
gene itself showed high levels of conservation in some areas
but with a hypervariable repeat region: no two isolates were
identical.
The galactopyranose mutase gene glf was seen in 24 pneu-
mococcal samples (accession nos HE651275–7, HE651284,
HE651288, HE651290–6, HE651298, HE651304–7, HE651309–
11, HE651313, HE651316–7, HE651320) alongside a conserved
gene cluster with aliB-like genes, similar to that described
elsewhere in non-encapsulated lineages(Hathaway et al.,2004).
In 14 cases a putative toxin–antitoxin system was also present
(strains marked as ‘cluster 1’ and ‘cluster 2’ in Table S1).
Eleven non-pneumococcal isolates (accession nos HE651264–
74) were referred from the array as positive for glf. All were
shown also to have aliB genes very similar to non-encapsulated
Table 2. Screening primer sequences for groups NT1, NT2 and NT3
See Table S2 for details of use and product sizes.
Primer and application Sequence (5§–3§)
Cps_F GACCAAGAATACCGCGAAAA
Cps_R AACATCCTTCCATTCATCCC
Spans the cps locus, primers in conserved dexB and aliA flanking genes.
May be used to identify deletions by length (NT1)
nspA_F GATGAGTTTGGCAAGCGTGG
nspA_R AAGCAAGTGCAACATTGTCC
Within gene nspA (NT2)
aliB1_F AAAGTGGCTCTTAGGAGCAGG
aliB1_R TTGCCARTTRTTGAAGGC
Within the first aliB gene (NT3 and non-pneumococcal)
aliB2_F GATGGTTTGYTWGAAAATGAC
aliB2_R AGAGARTTRTCAATCATCCAAGC
Within the second aliB gene (NT3 and non-pneumococcal)
Table 1. cont.
Sample name [GenBank accession no.] Species Country of origin Serotype* Non-typable group
GM66782 [HE651268] S. pseudopneumoniae The Gambia Non-encapsulated
GM73924 [HE651269] Unidentified (S. pneumoniae
or S. pseudopneumoniae)
The Gambia Non-encapsulated
1071-01 [HE651273] S. mitis Denmark Non-encapsulated
1298-02 [HE651274] S. mitis Denmark Non-encapsulated
958-02 [HE651270] S. pseudopneumoniae Denmark Non-encapsulated
*Serotype according to Quellung reaction.
Capsule locus variation in the pneumococcus
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1564 Microbiology 158pneumococci. The aliB gene sequences of these and the
pneumococci do not cluster according to the species or
geographical location of isolation.
DISCUSSION
Conflicts between serotyping and microarray
Isolate 557B (Fig. 1a) is serologically type 33C, reacting
with antiserum 33e, but has a mosaic cps cluster made up
of 33B-like and 33C-like genes. wcjG, wciN, wcrO and the
first half of wcrC are similar to the 33C reference sequence
(99% nucleotide identity), while the second half of wcrC,
and wciD, wciE and wciF, are similar to 33B (99%
nucleotide identity). The polymerase and flippase wzy
and wzx are not similar to any known serotypes, which is
consistent with their function transporting and polymer-
izing a different subunit structure. Following wzx are 33C-
like glf and wcyO (98% nucleotide identity).
Predicting the structure using the association of function
with protein families (Aanensen et al., 2007) suggests that
most of the polysaccharide repeat subunit of 557B is 33B-
like, with the exception of the 33C-like glycosyltransferase
WciN, which may or may not be functional in serotype
33C. As the structure of 33C has not been elucidated, the
acetylation pattern brought about by WcyO cannot be
inferred. The Wzy-mediated linkage cannot be predicted
from the DNA sequence.
The sequence of 557B has greater than 99% nucleotide
identity with partial sequences of an unpublished pneu-
mococcal strain described as a new serogroup 33 member,
33E (gi: 46277554, 158454747, 158454749), including the
divergent wzx and wzy genes. Discriminatory serum
development is ongoing: currently this appears similar to
antiserum 33e, having a positive reaction to 33C and a
weak reaction to 33F.
Isolate L2008-01622 is serologically type 22F but does not
have the glycosyl and acetyltransferases wcwA and wcwC
according to array analysis. In their places are divergent
genes that contain conserved glycosyltransferase domains
andacetyltransferasehexapeptiderepeats,respectively.More
work is needed to confirm the function of these genes.
Further investigation into the reference strain for 22F
(Bentley et al., 2006) led us to discover that the published
sequence for this type is not representative of the genes
present at its cps locus. The genes in place of wcwA and
wcwC, reported here as strain 1772-40b, are identical to
those of L2008-01622. These genes have not been reported
elsewhere and so may not be present in all 22F isolates;
however, they are present in the reference strain.
The presence of serotypable isolates that do not possess the
expected cps genes demonstrates the diversity that may
exist within a serotype and the importance of screening
all capsule biosynthesis genes when attempting to infer
serotype by DNA-based methods.
Deletion of genes at the cps locus: group NT1
Isolates GM90852, GM108225 and 2489-06 have a complete
loss of the cps gene cluster, as illustrated in Fig. 1(b). At the
locus the first has a putative IS1202 and truncated glf, while
the last two show only IS1202. The insertion sequence itself
is truncated at the 39 end by a RUP (repeat unit of pneu-
mococcus)element (Oggioni& Claverys, 1999) in GM90852
and GM108225. These latter two isolates represent inde-
pendent deletion events, as the 300–700 bp of flanking
DNA is different in each. Non-typable pneumococci with
a complete loss of cps genes can be identified by PCR
screening, as described in Table S2.
Disruption or partial deletion of the cps locus is a common
inactivator of capsule biosynthesis, for example making up
13% of the non-typable isolates in an Australian carriage
Fig. 1. cps locus gene content in non-typable and mistyped S. pneumoniae. Colour scheme is based on that of Aanensen et al.
(2007): dark blue (regulatory genes), dark purple (initial transferase), violet (polymerase), yellow (flippase), pale blue
(glycosyltransferase), white (acetyltransferase), pink (transposase, insertion sequence delimited by box), hatched pink (group II
intron), green (dTDP-L-rhamnose pathway genes), light brown (glucose dehydrogenase), hatched grey (epimerase), grey (UDP-
galactopyranose mutase), blue (surface protein), hatched green (aliB), hatched blue (toxin–antitoxin), dark brown
(pseudogene), black (flanking genes). (a) Isolate 557B. The gene cluster is a mosaic of serotype 33B- and 33C-like genes
with divergent regulatory genes, polymerase and flippase. The novel cluster produces a capsular polysaccharide that is
serologically type 33C but is predicted to have a different subunit structure. (b) Complete cps gene cluster deletions. Isolate
90852, top, retains a truncated glf along with an IS1202-like sequence that is truncated at the 39 end by a RUP element
(striped box). Isolate 108225, middle, has only the insertion sequence IS1202. Isolate 2489-06, bottom, contains the complete
IS1202 sequence. Nucleotide similarity is indicated by grey boxes. (c) Serotype 1, top, and the deletion in isolates 1621, 1629,
1630 and 1636, bottom. The functional portion of the biosynthesis cluster has been lost, presumably due to recombination
between the identical flanking IS1167 sequences. Nucleotide similarity is indicated by grey boxes. (d) Serotype 14, top, and the
deletion in isolate 96650, bottom. The regulatory genes are absent, in their place is a novel insertion sequence, ISSpn8. The
surface protein gene lrp is shorter due to a reduced number of repeat domains, and a group II intron has inserted downstream of
the cluster. Nucleotide similarity is indicated by grey boxes. (e) Aligned examples of nspA clusters. Isolates 890, top; 933,
middle; 2437, bottom. Nucleotide similarity is indicated by grey boxes. (f) Comparison of the widespread aliB-containing cluster
1, top, and cluster 2, bottom. Cluster 2 is similar to 1, with the addition of the novel ISSpn10 and a premature stop in the second
aliB. Nucleotide similarity is indicated by grey boxes.
Capsule locus variation in the pneumococcus
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01621, L2008-01629, L2008-01630 and L2008-01636, were
found to possess only the rhamnose genes rmlACBD by
array: the fully sequenced locus also contains flanking
IS1167 elements and an aliB pseudogene. The rmlACBD
cluster is identical to that of serotype 1 (Fig. 1c), suggesting
that these isolates lost the functional portion of the capsule
cluster by recombination at the identical flanking IS1167
sequences, similar to the cps acquisition scenario described
elsewhere (Mun ˜oz et al., 1997). Non-encapsulated pneu-
mococci rarely cause invasive disease. Demonstrating that
the deletion existed before disease is beyond the scope of
this paper; however, the presence of four identical deletion
events from four patients seems unlikely to have been an in
vitro event after isolation.
A deletion from serotype 14 was also predicted by the
array, with genes encoding the capsule subunit relocation
machinery and the first 330 bp of the initial transferase all
absent from sample GM96650 (Fig. 1d). A novel IS30 family
insertion sequence ISSpn8 is present at the site of the
3979 bp deletion. The surface protein gene lrp is shorter
in sample GM96650 (2163 bp) than in other reported
sequences {CGSP14 [gi: 182682970], 2499 bp; strain 34359
[gi: 68642995], 4216 bp; JJA [gi: 225722171], 6174 bp}. This
is due to the presence of only two copies of the Cna protein
B-type repeat (PF05738) compared with five copies in JJA.
The capsule gene cluster also contains an inserted, but not
disruptive, group II intron.
Lineages which are normally encapsulated have been shown
here to have become non-typable through complete or
partial deletion of the capsule gene cluster, a division among
the non-typables that we designate NT1, similar to the ‘NT
group I’ of a recent serotyping paper (Yu et al., 2011). The
isolates were from both carriage and disease, suggesting that
it may not always be disadvantageous to lose the capsule.
Putative novel surface protein NspA: group NT2
Twelve isolates (Tables 1 and S1) from Thailand and the
Netherlands have no cps genes at the locus, but instead
contain a gene predicted to produce a novel surface
protein, nspA (non-typable pneumococcal surface protein).
nspA is of variable length, ranging from approximately 1.1
to 1.7 kb among these isolates.
Upstream of nspA are 210 and 235 promoter sequences.
Analysis of the predicted amino acid sequence suggests that
there is a cleavable signal peptide, an LPXTG surface anchor
motif, and a variable-length glutamic acid-rich helical repeat
region from 3 to 27 repeats. Excluding the repeat region, the
encoded protein differs by 4% of the amino acids among
all sequenced isolates. Half of these differences are present
in only two isolates: RUNMC819 and 07B00830. There
is an identical frameshift in four samples (RUNMC819,
07B00830, 08B00930 and 08B01575), confirmed by rese-
quencing, caused by a single base deletion that affects codon
134/135.
The predicted protein contains a conserved KRNYPT motif
that may indicate a human polymeric Ig receptor (hpIgR)
binding function similar to that of the pneumococcal CbpA
(Elm et al., 2004). pIgR is an integral membrane glycopro-
tein of mucosal epithelial cells, crucial in the release of
secretory IgA into the mucosal secretions. The extracellular
region has five Ig-like domains, D1–5, of which D3 and D4
have been shown to interact with the YRNYPT motif of
CbpA. CbpA–hpIgR binding in vitro leads to adhesion to the
epithelium and internalization (Elm et al., 2004), and NspA
may have a similar function.
nspA is flanked by combinations of intact and disrupted IS
elements, illustrated in Fig. 1(e). All sequenced samples
contain a partial IS1202 truncated by a RUP element
identical to that seen in the cps deletions (group NT1),
and a putative IS66-family sequence with 93% nucleotide
identity to IS66 element ORF1, 2 and 3 in TIGR4. In
sample RUNMC2437, the IS66-like sequence contains a
RUP element that disrups ORF3, at the same site as in
TIGR4 and in published encapsulated sequences such as
serotype 43.
Four samples also contain an intact IS1167, similar at 93%
nucleotide identity to TIGR4 IS1167, while in eight other
samples only the 39 end of IS1167 is present. As well as
IS1202 and IS66, sample 07B00890 contains a novel IS30-
family insertion sequence, ISSpn9, most similar to Strep-
tococcus mitis B6 ISSmi3 (94% nucleotide identity).
There are a variety of insertion sequences flanking nspA,
some of which are found in typable cps loci and may
therefore provide potential recombination points, facilitat-
ing the spread of the gene between pneumococcal lineages.
It is consistent with the observation that the MLST data for
these strains (Table S1) show clearly that nspA is not
restricted to a single lineage of closely related pneumococci,
but is instead found in isolates that appear to be distantly
related. This, taken together with the source of these strains
from locations as distant as Thailand and the Netherlands,
also indicates that strains bearing this gene are quite
successful.
Authors’ note: after the acceptance of this manuscript, the
nucleotide sequences of other examples of this gene were
released, named pspK. To our knowledge, pspK has not yet
been described, but it leads us to conclude that the recent
grouping ‘NT group II clade I’ (Yu et al., 2011) is similar to
NT2.
aliB-like genes in S. pneumoniae: group NT3
Twenty-four samples have a well-conserved aliB gene cluster
(Fig. 1f). The non-encapsulated sequence types 448 and 449
are among these, lineages which circulate internationally,
and can make up 11% of non-typable isolates in carriage
(Marsh et al., 2010) and have been associated with con-
junctivitis in the USA for more than 20 years (Hanage et al.,
2006).For 14 samples (‘cluster 1’ and ‘cluster 2’; Table 1)the
locus is almost identical to that described in strain 110.58
S. J. Salter and others
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genes, a glf pseudogene and a putative toxin–antitoxin sys-
tem. A further two pneumococcal isolates have only one
aliB. AliB has been shown to aid colonization in two
knockout studies (Hathaway et al., 2010; Kerr et al., 2004),
affecting uptake of glutamic acid and early growth rates in a
mouse model.
The sequence of cluster 1 is identical to published strain
110.58 [gi: 50540968]. Cluster 2 is similar, but the genes
are preceded by a novel IS110-family insertion sequence,
ISSpn10, and the second aliB gene is disrupted by a
premature stop codon in all cases.
The putative toxin–antitoxin system of cluster 1 and cluster
2, ntaA and ntaB (non-typable toxin-antitoxin gene A,
antitoxin, and B, toxin), is similar to two Lactobacillus
salivarius UCC118 genes [gi: 90821554, gi: 90821553] and
their flanking sequences with 87% nucleotide identity.
ntaB contains a conserved Fic/DOC domain. The pre-
sence of a maintenance system such as this may contri-
bute to the persistence of this gene cluster in temporally
and geographically distant isolates, and provide some
explanation for the divergence of the identical aliB
sequences in this clade compared with pneumococcal
and non-pneumococcal aliB clusters that lack ntaAB
(Fig. 2).
Other streptococci
Eleven non-pneumococcal carriage isolates with glf genes
identified by microarray also contain aliB genes. Six
Streptococcus pseudopneumoniae, three S. mitis and one
unidentified isolate have a single aliB, while one S. mitis
contains two aliB genes (Table S1). Where a single gene is
present, it is most similar to the second consecutive aliB of
the group NT3 clusters. All of these aliBs are more similar
to non-typable S. pneumoniae (97 and 94% nucleotide
identity for the first and second aliB, respectively) than
published S. mitis {[gi: 92109246] 81 and 79%, respectively}
or Streptococcus oralis sequences {[gi: 92109243] 81 and
80%, respectively}.
As shown in Fig. 2, the sequences of aliB do not cluster
exclusively by species or geographical origin, in keeping
with the known presence of inter-species recombination
between nasopharyngeal streptococci (Donati et al., 2010).
Isolates such as 0900-07 also fall into different groups when
classified by the sequence of the first or second aliB
(data not shown), suggesting that there may be a mosaic
acquisition of these genes. Non-pneumococcal streptococci
have capsule-like genes at the cps locus, such as the RPS
(receptor polysaccharide) cluster in S. oralis (Yang et al.,
2009) and S. mitis (Yoshida et al., 2006), and they have
been shown to be functionally transferrable between species
Fig. 2. Tree of nucleotide similarity of the second aliB gene. A single representative from the identical aliB cluster 1 and 2 was
used along with divergent pneumococcal sequences, non-pneumococcal streptococci and three published pneumococcal
strains: 110.58, 106.44 and 208.56 (Hathaway et al., 2004). The outgroup is an aligned sequence from the first aliB in the
cluster of strain 110.58. Where a species is not specified, the isolate is S. pneumoniae. Although S. mitis and S.
pseudopneumoniae tend to fall together, pneumococcal isolates are also found in those groups, suggesting that these genes
have been acquired by different species recently. The branch identified by the bracket contains isolates that also have the toxin–
antitoxin system at the cps locus: the aliB sequence is highly conserved and geographically widespread.
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commensal species is further evidence that streptococci have a
large reservoir of genetic material at their disposal.
Conclusion
The results described here reveal previously unknown
variation at the cps locus. As well as divergent genes directly
involved in capsule synthesis, we have found others such as
aliB and nspA that may be advantageous in carriage, and
instances of capsule inactivation by deletion.
The mosaic acquisition of capsule biosynthesis genes from
serotype 33B and 33C clusters in 557B demonstrates the
potential for novel pneumococcal serotypes to be generated
by recombination. Conversely, two 22F strains possess novel
glycosyl and acetyltransferases that differ from the reference
sequence, indicating that caution is required when DNA-
based serotyping is reliant on few sequenced isolates.
Non-pneumococcal streptococci such as S. mitis can have
capsule-like genes at an equivalent locus to S. pneumoniae.
Pathogenand non-pathogenspeciesareknowntorecombine
with one another, and the ultimate origins and evolutionary
history of the capsule loci may include recombination
between the pneumococcus and other streptococcal species.
Here we have shown that S. pneumoniae-like aliB genes are
present in other species, do not cluster according to species
or geographical provenance, and so may be circulating
globally in the nasopharyngeal microbiota genetic pool.
The highly recombinogenic capsule locus is a straightfor-
wardPCR screening target because it is flanked by conserved
dexB and aliA genes. Several novel genes and gene variants
are described here with screening primers and expected
results to facilitate others in exploring diversity at the cps
locus in non-typable pneumococci.
ACKNOWLEDGEMENTS
This work was supported by Wellcome Trust grant 076964. P.T. is
supported by Wellcome Trust grant number 083735; W.P.H. has
been supported by the Royal Society (University Research Fellowship)
and National Institute of General Medical Sciences award number
U54GM088558; H.J.B. is supported by European Community’s
Seventh Framework Programme FP7/2007-2013 under grant agree-
ment number HEALTH-F3-2009-222983 (Pneumopath project). We
would like to thank the Sanger core sequencing team and Christa van
der Gaast-de Jongh for technical assistance, and Nicholas Croucher
for his comments on this manuscript.
REFERENCES
Aanensen, D. M., Mavroidi, A., Bentley, S. D., Reeves, P. R. & Spratt,
B. G. (2007). Predicted functions and linkage specificities of the
products of the Streptococcus pneumoniae capsular biosynthetic loci.
J Bacteriol 189, 7856–7876.
Ansaldi, F., Canepa, P., de Florentiis, D., Bandettini, R., Durando, P.
& Icardi, G. (2011). Increasing incidence of Streptococcus pneumoniae
serotype 19A and emergence of two vaccine escape recombinant
ST695 strains in Liguria, Italy, 7 years after implementation of the 7-
valent conjugated vaccine. Clin Vaccine Immunol 18, 343–345.
Beall, B. W., Gertz, R. E., Hulkower, R. L., Whitney, C. G., Moore, M. R.
& Brueggemann, A. B. (2011). Shifting genetic structure of invasive
serotype 19A pneumococci in the United States. J Infect Dis 203,
1360–1368.
Bentley, S. D., Aanensen, D. M., Mavroidi, A., Saunders, D.,
Rabbinowitsch, E., Collins, M., Donohoe, K., Harris, D., Murphy, L.
& other authors (2006). Genetic analysis of the capsular biosynthetic
locus from all 90 pneumococcal serotypes. PLoS Genet 2, e31.
Bonfield, J. K., Smith, K. F. & Staden, R. A. (1995). A new DNA
sequence assembly program. Nucleic Acids Res 23, 4992–4999.
Brueggemann, A. B., Peto, T. E. A., Crook, D. W., Butler, J. C., Kristinsson,
K. G. & Spratt, B. G. (2004). Temporal and geographic stability of the
serogroup-specific invasive disease potential of Streptococcus pneumoniae
in children. JI n f e c tD i s190, 1203–1211.
Brueggemann, A. B., Pai, R., Crook, D. W. & Beall, B. (2007). Vaccine
escape recombinants emerge after pneumococcal vaccination in the
United States. PLoS Pathog 3, e168.
Brugger, S. D. F., Frey, P., Aebi, S., Hinds, J. & Mu ¨hlemann, K. (2010).
Multiple colonization with S. pneumoniae before and after introduc-
tion of the seven-valent conjugated pneumococcal polysaccharide
vaccine. PLoS ONE 5, e11638.
Cole, J. R., Chai, B., Farris, R. J., Wang, Q., Kulam-Syed-Mohideen,
A. S., McGarrell, D. M., Bandela, A. M., Cardenas, E., Garrity, G. M. &
Tiedje, J. M. (2007). The ribosomal database project (RDP-II):
introducing myRDP space and quality controlled public data. Nucleic
Acids Res 35 (Database issue), D169–D172.
Croucher, N. J., Harris, S. R., Fraser, C., Quail, M. A., Burton, J.,
van der Linden, M., McGee, L., von Gottberg, A., Song, J. H. & other
authors (2011). Rapid pneumococcal evolution in response to clinical
interventions. Science 331, 430–434.
Dagan, R., Givon-Lavi, N., Leibovitz, E., Greenberg, D. & Porat, N.
(2009). Introduction and proliferation of multidrug-resistant
Streptococcus pneumoniae serotype 19A clones that cause acute otitis
media in an unvaccinated population. J Infect Dis 199, 776–785.
Delcher, A. L., Harmon, D., Kasif, S., White, O. & Salzberg, S. L.
(1999). Improved microbial gene identification with GLIMMER. Nucleic
Acids Res 27, 4636–4641.
Donati, C., Hiller, N. L., Tettelin, H., Muzzi, A., Croucher, N. J., Angiuoli,
S. V., Oggioni, M., Dunning Hotopp, J. C., Hu, F. Z. & other authors
(2010). Structure and dynamics of the pan-genome of Streptococcus
pneumoniae and closely related species. Genome Biol 11, R107.
Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high
accuracy and high throughput. Nucleic Acids Res 32, 1792–1797.
Elm, C., Braathen, R., Bergmann, S., Frank, R., Vaerman, J.-P.,
Kaetzel, C. S., Chhatwal, G. S., Johansen, F.-E. & Hammerschmidt,
S. (2004). Ectodomains 3 and 4 of human polymeric immunoglo-
bulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae
into the epithelium. J Biol Chem 279, 6296–6304.
Gouy, M., Guindon, S. & Gascuel, O. (2010). SeaView version 4: a
multiplatform graphical user interface for sequence alignment and
phylogenetic tree building. Mol Biol Evol 27, 221–224.
Hammerschmidt, S., Wolff, S., Hocke, A., Rosseau, S., Mu ¨ller, E. &
Rohde, M. (2005). Illustration of pneumococcal polysaccharide
capsule during adherence and invasion of epithelial cells. Infect
Immun 73, 4653–4667.
Hanage, W. P., Kaijalainen, T. H., Syrja ¨nen, R. K., Auranen, K.,
Leinonen, M., Ma ¨kela ¨, P. H. & Spratt, B. G. (2005). Invasiveness of
serotypes and clones of Streptococcus pneumoniae among children in
Finland. Infect Immun 73, 431–435.
S. J. Salter and others
1568 Microbiology 158Hanage, W. P., Kaijalainen, T., Saukkoriipi, A., Rickcord, J. L. &
Spratt, B. G. (2006). A successful, diverse disease-associated lineage of
nontypeable pneumococci that has lost the capsular biosynthesis
locus. J Clin Microbiol 44, 743–749.
Hathaway,L. J., Stutzmann Meier, P., Ba ¨ttig, P., Aebi,S.& Mu ¨hlemann,
K. (2004). Ah o m o l o g u eo faliB is found in the capsule region of
nonencapsulated Streptococcus pneumoniae. JB a c t e r i o l186, 3721–3729.
Hathaway,L.J., Ba ¨ttig, P., Aebi,S., Reber,S., Brewin, H., Kadioglu, A.&
Mu ¨hlemann, K. (2010). aliB-like ORF 1 aids growth by playing a role in
the uptake of glutamic acid. In 7th International Symposium on
Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel.
Hulo, N., Bairoch, A., Bulliard, V., Cerutti, L., Cuche, B. A., de Castro,
E., Lachaize, C., Langendijk-Genevaux, P. S. & Sigrist, C. J. A.
(2008). The 20 years of PROSITE. Nucleic Acids Res 36 (Database issue),
D245–D249.
Johnson, H. L., Deloria-Knoll, M., Levine, O. S., Stoszek, S. K.,
Freimanis Hance, L., Reithinger, R., Muenz, L. R. & O’Brien, K. L.
(2010). Systematic evaluation of serotypes causing invasive pneumo-
coccal disease among children under five: the pneumococcal global
serotype project. PLoS Med 7, e1000348.
Kerr,A.R.,Adrian, P.V., Esteva ˜o,S., deGroot,R., Alloing,G.,Claverys,
J.-P., Mitchell, T. J. & Hermans, P. W. M. (2004). The Ami-AliA/AliB
permease of Streptococcus pneumoniae is involved in nasopharyngeal
colonization but not in invasive disease. Infect Immun 72, 3902–3906.
Kim, J. O., Romero-Steiner, S., Sørensen, U. B., Blom, J., Carvalho,
M., Barnard, S., Carlone, G. & Weiser, J. N. (1999). Relationship
between cell surface carbohydrates and intrastrain variation on
opsonophagocytosis of Streptococcus pneumoniae. Infect Immun 67,
2327–2333.
Kirkham, L.-A. S., Jefferies, J. M. C., Kerr, A. R., Jing, Y., Clarke, S. C.,
Smith, A. & Mitchell, T. J. (2006). Identification of invasive serotype 1
pneumococcal isolates that express nonhemolytic pneumolysin. J Clin
Microbiol 44, 151–159.
Llull, D., Mun ˜oz, R., Lo ´pez, R. & Garcı ´a, E. (1999). A single gene (tts)
located outside the cap locus directs the formation of Streptococcus
pneumoniae type 37 capsular polysaccharide. Type 37 pneumococci
are natural, genetically binary strains. J Exp Med 190, 241–252.
Marsh, R., Smith-Vaughan, H., Hare, K. M., Binks, M., Kong, F.,
Warning, J., Gilbert, G. L., Morris, P. & Leach, A. J. (2010). The
nonserotypeable pneumococcus: phenotypic dynamics in the era of
anticapsular vaccines. J Clin Microbiol 48, 831–835.
McMurray, A. A., Sulston, J. E. & Quail, M. A. (1998). Short-insert
libraries as a method of problem solving in genome sequencing.
Genome Res 8, 562–566.
Melin, M., Trzcin ´ski, K., Meri, S., Ka ¨yhty, H. & Va ¨keva ¨inen, M. (2010).
The capsular serotype of Streptococcus pneumoniae is more important
than the genetic background for resistance to complement. Infect
Immun 78, 5262–5270.
Mizrachi Nebenzahl, Y., Porat, N., Lifshitz, S., Novick, S., Levi, A.,
Ling, E., Liron, O., Mordechai, S., Sahu, R. K. & Dagan, R. (2004).
Virulence of Streptococcus pneumoniae may be determined indepen-
dently of capsular polysaccharide. FEMS Microbiol Lett 233, 147–152.
Moore, M. R., Gertz, R. E., Jr, Woodbury, R. L., Barkocy-Gallagher,
G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M.
& other authors (2008).Populationsnapshotofemergent Streptococcus
pneumoniae serotype 19A in the United States, 2005. JI n f e c tD i s197,
1016–1027.
Mun ˜oz, R., Mollerach, M., Lo ´pez, R. & Garcı ´a, E. (1997). Molecular
organization of the genes required for the synthesis of type 1 capsular
polysaccharide of Streptococcus pneumoniae: formation of binary
encapsulated pneumococci and identification of cryptic dTDP-
rhamnose biosynthesis genes. Mol Microbiol 25, 79–92.
Mun ˜oz-Almagro, C., Esteva, C., de Sevilla, M. F., Selva, L., Gene, A. &
Pallares, R. (2009). Emergence of invasive pneumococcal disease
caused by multidrug-resistant serotype 19A among children in
Barcelona. J Infect 59, 75–82.
O’Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M.,
McCall, N., Lee, E., Mulholland, K., Levine, O. S., Cherian, T. & Hib
and Pneumococcal Global Burden of Disease Study Team (2009).
Burden of disease caused by Streptococcus pneumoniae in children
younger than 5 years: global estimates. Lancet 374, 893–902.
Oggioni, M. R. & Claverys, J.-P. (1999). Repeated extragenic sequences
in prokaryotic genomes: a proposal for the origin and dynamics of the
RUP element in Streptococcus pneumoniae. Microbiology 145, 2647–
2653.
Paton, J. C. & Morona, J. K. (2007). Pneumococcal capsular
polysaccharides: biosynthesis and regulation. In Molecular Biology of
Streptococci, pp. 119–140. Edited by R. Hakenbeck & G. S. Chhatwal.
Wymondham, UK: Horizon Bioscience.
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P.,
Rajandream, M. A. & Barrell, B. (2000). Artemis: sequence
visualization and annotation. Bioinformatics 16, 944–945.
Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA sequencing with
chain-terminating inhibitors. Proc Natl Acad Sci U S A 74, 5463–5467.
Shin, J., Baek, J. Y., Kim, S. H., Song, J.-H. & Ko, K. S. (2011).
Predominance of ST320 among Streptococcus pneumoniae serotype
19A isolates from 10 Asian countries. J Antimicrob Chemother 66,
1001–1004.
Siguier, P., Perochon, J., Lestrade, L., Mahillon, J. & Chandler, M.
(2006). ISfinder: the reference centre for bacterial insertion sequences.
Nucleic Acids Res 34 (Database issue), D32–D36.
Temime, L., Boelle, P.-Y., Opatowski, L. & Guillemot, D. (2008).
Impact of capsular switch on invasive pneumococcal disease
incidence in a vaccinated population. PLoS ONE 3, e3244.
Turner, P. H., Hinds, J., Turner, C., Jankhot, A., Gould, K., Bentley,
S. D., Nosten, F. & Goldblatt, D. (2011). Improved detection of
nasopharyngeal co-colonization by multiple pneumococcal serotypes
by use of latex agglutination or molecular serotyping by microarray.
J Clin Microbiol 49, 1784–1789.
van Selm, S., van Cann, L. M., Kolkman, M. A., van der Zeijst, B. A. M.
& van Putten, J. P. M. (2003). Genetic basis for the structural
difference between Streptococcus pneumoniae serotype 15B and 15C
capsular polysaccharides. Infect Immun 71, 6192–6198.
Waite, R. D., Penfold, D. W., Struthers, J. K. & Dowson, C. G. (2003).
Spontaneous sequence duplications within capsule genes cap8E and
tts control phase variation in Streptococcus pneumoniae serotypes 8
and 37. Microbiology 149, 497–504.
Weinberger, D. M., Trzcin ´ski, K., Lu, Y.-J., Bogaert, D., Brandes, A.,
Galagan, J., Anderson, P. W., Malley, R. & Lipsitch, M. (2009).
Pneumococcal capsular polysaccharide structure predicts serotype
prevalence. PLoS Pathog 5, e1000476.
Yang, J., Ritchey, M., Yoshida, Y., Bush, C. A. & Cisar, J. O. (2009).
Comparative structural and molecular characterization of ribitol-5-
phosphate-containing Streptococcus oralis coaggregation receptor
polysaccharides. J Bacteriol 191, 1891–1900.
Yoshida, Y., Ganguly, S., Bush, C. A. & Cisar, J. O. (2006). Molecular
basis of L-rhamnose branch formation in streptococcal coaggregation
receptor polysaccharides. J Bacteriol 188, 4125–4130.
Yu, J., Lin, J., Kim, K.-H., Benjamin, W. H., Jr & Nahm, M. H. (2011).
Development of an automated and multiplexed serotyping assay for
Streptococcus pneumoniae. Clin Vaccine Immunol 18, 1900–1907.
Edited by: M. Kilian
Capsule locus variation in the pneumococcus
http://mic.sgmjournals.org 1569